Used in pharmaceutical research as an intermediate in the synthesis of bioactive molecules, particularly those targeting central nervous system disorders. Its structure supports development of compounds with potential antidepressant, anxiolytic, or stimulant effects. The fluorophenyl group enhances binding affinity to certain receptors, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in the design of novel amine-based derivatives for metabolic stability and improved pharmacokinetics.